These results demonstrate that PTX3 deficiency exerts a protective effect against STZ-induced deformation of pancreatic islets and β-cell death, highlighting PTX3 as a potential therapeutic target for diabetes mellitus. The gene discussed is PTX3; the disease is diabetes mellitus.